LAG3 and neoplasm: In one human study, the presence of anti-LAG3 blocking mAbs or a recombinant soluble form of LAG3 did not influence LAG3+ NK cell cytotoxicity against multiple tumor cell lines, suggesting that in humans, LAG3 may not have a major influence on NK cell activity [117].